Laura Wallace

Laura Wallace is the Head of Global Epidemiology and Real World Evidence at Boehringer Ingelheim, overseeing a diverse team across three continents and various therapeutic areas since December 2016. Previously, Laura served as Executive Director for Global Epidemiology within the Respiratory therapeutic area at the same company. Prior experience includes a role as Director of Risk Management & Epidemiology at Purdue Pharma L.P., where Laura led pediatric epidemiology efforts, and as Associate Director of Epidemiology at Pfizer, contributing to over 20 compounds' development and regulatory submissions. Educational credentials include a Master's Degree in Public Health from Southern Connecticut State University and a Bachelor's Degree in Psychology from the University of Alaska Fairbanks.